DuPont Wins 2026 R&D 100 Award for Healthcare Innovation

DuPont announced that it has won a 2026 R&D 100 Award in the Mechanical/Materials category, for its DuPont Liveo Pharma TPE Ultra-Low Temp Tubing product. The R&D 100 Awards, sponsored by R&D World Magazine, recognizes the 100 most innovative technologies of the previous year.

"We're honored to have one of our DuPont innovations recognized among the year's most significant technology achievements," said Marty DeGroot, DuPont Chief Technology Officer. "Winning an R&D 100 Award reflects the dedication and ingenuity of our teams, who continue to develop advanced technologies and solutions that deliver performance, value and meaningful impact for our customers."

DuPont™ Liveo Pharma TPE Ultra-Low Temp Tubing is designed for biopharmaceutical processing applications that require exposure to extremely low temperatures, Liveo Pharma TPE Ultra-Low Temp Tubing is a sterilizable, weldable, and sealable thermoplastic elastomer tubing manufactured in an ISO Class 7 cleanroom. The tubing maintains toughness and flexibility down to -86°C and offers strong resistance to bending, crushing, impact, chemicals, and burst pressure. Supported by a comprehensive regulatory and validation data package, it provides biopharma manufacturers with a high-purity solution for fluid transfer and single-use processing applications while expanding DuPont's portfolio of Liveo™ biopharma processing technologies.